{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:27:24Z","timestamp":1772854044635,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.dsx.2021.03.017","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T15:52:19Z","timestamp":1616514739000},"page":"695-701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lower versus standard sucrose dose for treating hypoglycemia in patients with type 1 diabetes mellitus in therapy with predictive low glucose suspend (PLGS) augmented insulin pumps: A randomized crossover trial in Santiago, Chile"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0095-9740","authenticated-orcid":false,"given":"Bruno","family":"Grassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Teresa","family":"Onetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1944-1650","authenticated-orcid":false,"given":"Yazm\u00edn","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Jofr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Echeverr\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.dsx.2021.03.017_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of Diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2021.03.017_bib2","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.dsx.2021.03.017_bib3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00592-015-0784-2","article-title":"Clinical review: insulin pump-associated adverse events in adults and children","volume":"52","author":"Ross","year":"2015","journal-title":"Acta Diabetol"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.dsx.2021.03.017_bib4","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1089\/dia.2014.1503","article-title":"Insulin pumps","volume":"16","author":"Pickup","year":"2014","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.dsx.2021.03.017_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/adc.78.2.111","article-title":"Impact of improved glycemic control on rates of hypoglycaemia in insulin dependent diabetes mellitus","volume":"78","author":"Davis","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.dsx.2021.03.017_bib6","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/dc12-2480","article-title":"Hypoglycemia and diabetes: a report of a workgroup of the American diabetes association and the endocrine society","volume":"36","author":"Seaquist","year":"2013","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.dsx.2021.03.017_bib7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11892-013-0411-y","article-title":"Hypoglycemia in patients with type 1 diabetes: epidemiology, pathogenesis, and prevention","volume":"13","author":"Awoniyi","year":"2013","journal-title":"Curr Diabetes Rep"},{"issue":"Suppl 1","key":"10.1016\/j.dsx.2021.03.017_bib8","article-title":"Hypoglycemia, Diabetes, and cardiovascular disease","volume":"14","author":"Snell-Bergeon","year":"2012","journal-title":"Diabetes Technol Therapeut"},{"issue":"8","key":"10.1016\/j.dsx.2021.03.017_bib9","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/(SICI)1096-9136(199708)14:8<648::AID-DIA418>3.0.CO;2-1","article-title":"Altered ventricular repolarization during hypoglycaemia in patients with Diabetes","volume":"14","author":"Marques","year":"1997","journal-title":"Diabet Med"},{"issue":"Suppl 1","key":"10.1016\/j.dsx.2021.03.017_bib10","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.diabres.2004.07.008","article-title":"Morbidity of hypoglycemia in type 1 diabetes","volume":"65","author":"Frier","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.dsx.2021.03.017_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00125-008-1177-7","article-title":"Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes\u2013the \u2019dead in bed\u2019 syndrome revisited","volume":"52","author":"Gill","year":"2009","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.dsx.2021.03.017_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/dmrr.865","article-title":"Vascular disease and Diabetes: is hypoglycaemia an aggravating factor?","volume":"24","author":"Wright","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"10.1016\/j.dsx.2021.03.017_bib13","first-page":"646","article-title":"Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs","volume":"14","author":"Fidler","year":"2011","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.dsx.2021.03.017_bib14","first-page":"CD005103","article-title":"Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus","volume":"1","author":"Misso","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl.1","key":"10.1016\/j.dsx.2021.03.017_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00592-009-0132-5","article-title":"Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis","volume":"47","author":"Monami","year":"2010","journal-title":"Acta Diabetol"},{"issue":"3","key":"10.1016\/j.dsx.2021.03.017_bib16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/jc.2008-1415","article-title":"Clinical review: hypoglycemia with intensive insulin therapy: systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections","volume":"94","author":"Fatourechi","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2021.03.017_bib17","series-title":"Chapter 1, Rebekah Renshaw. Putting you Patients on the pump","author":"Bolderman","year":"2002"},{"key":"10.1016\/j.dsx.2021.03.017_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2337\/diacare.25.3.593","article-title":"Continuous Subcutaneous Insulin Infusion at 25 Years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes","volume":"25","author":"Pickup","year":"2002","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.dsx.2021.03.017_bib19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1089\/dia.2015.0324","article-title":"Hypoglycemia prevention and user acceptance of an insulin pump system with predictive low glucose management","volume":"18","author":"Choudhary","year":"2016","journal-title":"Diabetes Technol Therapeut"},{"issue":"6","key":"10.1016\/j.dsx.2021.03.017_bib20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-8587(19)30150-0","article-title":"Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial","volume":"7","author":"Bosi","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.dsx.2021.03.017_bib21","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1001\/jama.1984.03350240024032","article-title":"Treatment of insulin reactions in diabetics","volume":"252","author":"Brodows","year":"1984","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.dsx.2021.03.017_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archinte.1990.00390150083016","article-title":"The search for an optimized treatment of hypoglycemia","volume":"150","author":"Slama","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.dsx.2021.03.017_bib23","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/diacare.16.8.1131","article-title":"Alanine and terbutaline in treatment of hypoglycemia in IDDM","volume":"16","author":"Wiethop","year":"1993","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.dsx.2021.03.017_bib24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1399-5448.2009.00558.x","article-title":"The effectiveness of glucose, sucrose, and fructose in treating hypoglycemia in children with type 1 diabetes","volume":"11","author":"Husband","year":"2010","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.dsx.2021.03.017_bib26","series-title":"Chapter 8. Caring for diabetes in children and adolescents","author":"Ambler","year":"2010"},{"issue":"Supplement 1","key":"10.1016\/j.dsx.2021.03.017_bib27","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.2337\/dc21-S006","article-title":"Glycemic targets: standards of medical care in diabetes-2021","volume":"44","author":"American Diabetes Association","year":"2021","journal-title":"Diabetes Care Jan"},{"key":"10.1016\/j.dsx.2021.03.017_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/dme.13576","article-title":"Treatment Weight-based carbohydrate treatment of hypoglycaemia in people with Type 1 diabetes using insulin pump therapy: a randomized crossover clinical trial","author":"McTavish","year":"2018","journal-title":"Diabet Med"},{"issue":"12","key":"10.1016\/j.dsx.2021.03.017_bib29","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.2013.277818","article-title":"Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial","volume":"310","author":"Ly","year":"2013","journal-title":"J\u00a0Am Med Assoc"},{"issue":"11","key":"10.1016\/j.dsx.2021.03.017_bib30","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.2337\/db12-0224","article-title":"Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes","volume":"61","author":"Ceriello","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2021.03.017_bib31","article-title":"Predictive low-glucose suspend necessitates less carbohydrate supplementation to rescue hypoglycemia: need to revisit current hypoglycemia treatment guidelines","author":"Pinkser","year":"2021","journal-title":"Diabetes Technol Therapeut"},{"issue":"S2","key":"10.1016\/j.dsx.2021.03.017_bib32","doi-asserted-by":"crossref","first-page":"S250","DOI":"10.1089\/dia.2018.0113","article-title":"Hypoglycemia: new definitions and regulatory implications","volume":"20","author":"Ratner","year":"2018","journal-title":"Diabetes Technol Therapeut"},{"issue":"8","key":"10.1016\/j.dsx.2021.03.017_bib33","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.dsx.2021.03.017_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/dia.2016.0349","article-title":"Let the algorithm do the work\": reduction of hypoglycemia using sensor-augmented pump therapy with predictive insulin suspension (SmartGuard) in pediatric type 1 diabetes patients","volume":"19","author":"Biester","year":"2017","journal-title":"Diabetes Technol Therapeut"},{"issue":"1","key":"10.1016\/j.dsx.2021.03.017_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.dsx.2021.01.002","article-title":"Factors associated with clinically significant hypoglycemia in patients with type 1 diabetes using sensor-augmented pump therapy with predictive low-glucose management: a multicentric study on iberoamerica","volume":"15","author":"G\u00f3mez","year":"2021","journal-title":"Diabetes Metab Syndr"},{"issue":"12","key":"10.1016\/j.dsx.2021.03.017_bib36","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.2337\/db13-1132","article-title":"Time lag of glucose from intravascular to interstitial compartment in humans","volume":"62","author":"Basu","year":"2013","journal-title":"Diabetes"}],"updated-by":[{"DOI":"10.1016\/j.dsx.2022.102506","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000}}],"container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121000916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121000916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:15:48Z","timestamp":1761729348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402121000916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1871402121000916"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2021.03.017","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower versus standard sucrose dose for treating hypoglycemia in patients with type 1 diabetes mellitus in therapy with predictive low glucose suspend (PLGS) augmented insulin pumps: A randomized crossover trial in Santiago, Chile","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2021.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}